SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001493152-20-012802
Filing Date
2020-07-08
Accepted
2020-07-08 08:34:34
Documents
1
Period of Report
2020-07-06

Document Format Files

Seq Description Document Type Size
1 ownership.html 4  
1 ownership.xml 4 4050
  Complete submission text file 0001493152-20-012802.txt   5466
Mailing Address C/O CELGENE CORP. 86 MORRIS AVENUE SUMMIT NJ 07901
Business Address
Golumbeski George (Reporting) CIK: 0001586660 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-37348 | Film No.: 201017308

Mailing Address 500 RIVER RIDGE DRIVE NORWOOD MA 02062
Business Address 500 RIVER RIDGE DRIVE NORWOOD MA 02062 617-963-0103
Corbus Pharmaceuticals Holdings, Inc. (Issuer) CIK: 0001595097 (see all company filings)

IRS No.: 464348039 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations